Please find attached intimation of payment of interest and redemption amount to the NCD holders of the Company.

Debt PrepaidCredit & Debt View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.5%1-day move

₹2105.00

prior close

₹2112.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.2+0.0-0.2+1.5+4.5+6.2+9.2+7.6+7.6+16.8+18.7+12.6+17.8

Up moveDown movePending

AI summary

Mankind Pharma has paid interest and redeemed NCDs on April 16, 2026. The company paid a total gross interest of approximately ₹199 crore across three ISINs, with payments made on schedule. Additionally, one ISIN (INE634S07017) with a face value of ₹1,250 crore was fully redeemed at maturity, reducing outstanding NCD debt to zero. All payments were made on the due date with no delays or non-payments reported.

Likely market impact

This is a routine debt maturity repayment that reduces Mankind Pharma's debt obligations by ₹1,250 crore. The timely repayment indicates the company has sufficient liquidity to meet its debt commitments, which is a positive signal for bondholders and shareholders.